Market News & Trends
4/12/2011
IBM & the Institute of Bioengineering & Nanotechnology Find Breakthrough TreatmentResearchers from IBM and the Institute of Bioengineering and Nanotechnology recently discovered a nanomedicine breakthrough…
Antares Pharma Announces NDA Accepted for Filing
Antares Pharma, Inc. recently announced the NDA for Anturol Gel in patients with overactive bladder (OAB) was accepted for filing for review by the US…
Aptar Pharma Registers Contract Test Laboratories With US FDA
Aptar Pharma's French manufacturing sites in Le Vaudreuil and Val-de-Reuil have been registered as Contract Test Laboratories for extractables testing with the US FDA. A…
Comprehensive Clinical Development Finalizes Acquisition
Comprehensive Clinical Development, formerly operating as Comprehensive NeuroScience, Inc., a strategic clinical research organization delivering high-quality clinical development services from early proof-of-concept through commercialization, recently…
IBM & the Institute of Bioengineering & Nanotechnology Find Breakthrough Treatment
Researchers from IBM and the Institute of Bioengineering and Nanotechnology recently discovered a nanomedicine breakthrough in which new types of polymers were shown to physically…
3/29/2011
Champions Biotechnology Announces Technology Collaboration With CephalonChampions Biotechnology, Inc. recently announced the signing of a technology collaboration agreement with Cephalon, Inc. in which Champions will…
Champions Biotechnology Announces Technology Collaboration With Cephalon
Champions Biotechnology, Inc. recently announced the signing of a technology collaboration agreement with Cephalon, Inc. in which Champions will conduct low passage Tumorgraft studies on…
Drug Delivery International Seeks to Recruit Scientists
Drug Delivery International (DDi) is on the hunt for a clutch of world-class scientists as it embarks on an aggressive growth drive. And as it…
MethylGene Announces $34.5 Million Financing to Develop Oncology & Antifungal Drugs
MethylGene Inc. recently announced its intention to complete a private placement of $34.5 million. Institutional investors participating in the offering include a fund managed by…
Procter & Gamble & TEVA Form Consumer Healthcare Partnership
The Procter & Gamble Company and Teva Pharmaceutical Industries Ltd. recently announced the signing of a master agreement to create a partnership in consumer healthcare…
Seattle Genetics Announces Antibody-Drug Conjugate Collaboration With Abbott Laboratories
Seattle Genetics, Inc. recently announced it has entered into a collaboration agreement with Abbott under which Abbott will pay an upfront fee of $8 million…
Unigene's Oral Peptide Drug Delivery Technology Validated
Unigene Laboratories, Inc., a leader in the design, delivery, manufacture, and development of peptide-based therapeutics, recently announced that the statistically significant top-line results released by…
3/15/2011
Cytheris Announces Study Results Indicating CYT107 Expands CD4 T-Cells Cytheris SA, a clinical-stage biopharmaceutical company focused on research and development of new therapies for immune…
Alliqua Successfully Completes Next Milestone in Transdermal Pain Patch Development
Alliqua, Inc., an advanced biomedical products company focused on the development and manufacturing of proprietary drug delivery and liver health technologies, recently announced the successful…
Avantor Completes Acquisition of RFCL Limited
Avantor Performance Materials Holdings S.A. recently announced it has completed its acquisition of RFCL Limited from ICICI Venture Funds Management Company Limited. Avantor, previously known…
Cytheris Announces Study Results Indicating CYT107 Expands CD4 T-Cells
Cytheris SA, a clinical-stage biopharmaceutical company focused on research and development of new therapies for immune modulation, recently announced results of a multi-center Phase IIa…
Elan Announces First European Commission Approval of Injectable Treatment Using NanoCrystal Technology
Elan Drug Technologies (EDT), the leading drug delivery unit of Elan Corporation, plc, recently announced that the first injectable product using EDT's NanoCrystal technology has…
Omthera Raises $33.9 Million to Fund Phase III Development
Omthera Pharmaceuticals, Inc., a privately held emerging specialty pharmaceuticals company, recently announced it has raised $33.9 million in a Series B funding round, led by…
Ricerca Biosciences Announces Strategic Collaboration With Fulcrum
Ricerca Biosciences, an integrated preclinical CRO providing services to the biopharmaceutical industry, recently announced a strategic partnership with Fulcrum Pharma, an Aptiv Solutions company, a…
3/1/2011
Elan & PPD Announce Global Business Relationship in Drug Development Elan, plc and PPD, Inc. recently announced they have formed a global business collaboration focused…
